*  Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical...
There is accumulating evidence to suggest that different histological grades of invasive ductal breast carcinomas may have distinct molecular origins and pathogenesis and do not typically progress from one grade group to another (28, 29, 30, 31) . The different grades have different clinical behaviors, and within-grade studies to identify the more aggressive subgroups of these classes of breast tumors would be of great assistance in clinical management. The expression of basal/myoepithelial markers has been observed in a proportion of grade III invasive breast tumors, and the spectrum of basal-like tumors, also recognized by morphology (15 , 32) , molecular cytogenetics (16 , 33) , and expression profiling (18 , 19) , has been associated with poor prognosis (17) . CGH has the advantage of being applied to archival pathology specimens with long-term follow-up ...
  http://clincancerres.aacrjournals.org/content/10/18/5988.long
*  Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer | ScholarBank@NUS
Jin, R.,Bay, B.H.,Chow, V.T.K.,Tan, P.H.,Lin, V.C.L. (2000). Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer. British Journal of Cancer 83 (3) : 319-323. ScholarBank@NUS Repository ...
  http://scholarbank.nus.edu.sg/handle/10635/33867
*  Gentaur Molecular :US Biomax \ High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues,...
Gentaur molecular products has all kinds of products like :search , US Biomax \ High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_192 cores; ihc Anti-Actin confirmed \ BR1921 for more molecular products just contact us
  http://www.antibody-antibodies.com/product_det.php?id=1970452&supplier=search&name=High_density%20breast%20invasive%20ductal%20and%20lobular%20carcinoma%20tissue%20array%20with%20normal%20tissues,%20grading%20and%20staging%20data,192%20cases_192%20cores%3B%20ihc%20%20Anti_Actin%20confirmed
*  Most recent papers with the keyword Invasive ductal carcinoma | Read by QxMD
BACKGROUND Synchronous bilateral breast cancer is rare. A case is presented where whole breast irradiation (WBI) was planned after breast conserving surgery in a patient with synchronous bilateral breast cancer. A comparison was made between the feasibility of helical tomotherapy and direct tomotherapy. CASE REPORT A 60-year-old woman was found to have bilateral breast nodules on routine mammographic screening, resulting in bilateral lumpectomy and sentinel lymph node biopsy. Histopathology showed a 6 mm diameter invasive ductal carcinoma in the right breast (Grade 1, hormone receptor positive, HER2 negative) and an 8mm diameter tubular carcinoma in the left breast (Grade 1, hormone receptor positive, HER2 negative ...
  https://www.readbyqxmd.com/keyword/15477
*  Invasive ductal carcinoma | Breast Cancer Care
Invasive ductal carcinoma (IDC) is the most common form of breast cancer. Find out about IDC symptoms, diagnosis and treatment at Breast Cancer Care.
  https://www.breastcancercare.org.uk/information-support/facing-breast-cancer/diagnosed-breast-cancer/primary-breast-cancer/invasive-ductal-breast-cancer
*  Mammary Ductal Carcinoma | Technology Trends
approximately three-quarters of breast cancers Invasive ductal carcinoma - 55% of breast cancers Ductal carcinoma in situ - 13% Invasive lobular carcinoma - 5% The overall 5-year survival rate for both ... Ductal carcinoma in situ, on the other hand, is in itself harmless, although if untreated approximately 60% of these low grade DCIS lesions will become invasive over the course of 40 years in follow-up ...
  http://www.primidi.com/mammary_ductal_carcinoma
*  Invasive ductal carcinoma arising in ectopic breast tissue of the axilla. Case report and review of the literature - CNR Solar
Sanguinetti, Alessandro and Ragusa, Marco and Calzolari, Filippo and D'Ajello, Fabio and Fioriti, L. and Papini, D. and Sidoni, Angelo and Roila, F. and Avenia, Nicola (2010) Invasive ductal carcinoma arising in ectopic breast tissue of the axilla. Case report and review of the literature. Il giornale di chirurgia, 31 (8/9). pp. 383-386. ISSN 1971-145X ...
  http://eprints.bice.rm.cnr.it/7121/
*  Invasive Ductal Carcinoma Stages | Moffitt Cancer Center
Invasive ductal carcinoma stages provide physicians with a uniform way to describe how far a patient's cancer may have spread beyond its original location in a milk duct. This information can be helpful when evaluating treatment options, but it is not a prognostic indicator in and of itself. Many factors can influence a patient's outcome, so the best source of information for understanding a breast cancer prognosis is always a physician who is familiar with the patient's case.. In general, breast cancer stages are established based on three key variables: the size of a tumor, the extent of lymph node involvement and whether the cancer has spread to other areas of the body. This information may be obtained through a combination of clinical examinations, imaging studies, blood tests, lymph node removal and tissue samples (biopsies). If, based on the initial test results, a physician believes that the cancer ...
  https://moffitt.org/cancers/invasive-ductal-carcinoma/stages/
*  Plus it
Background: Mounting evidence indicates that tumor-specific host immunity is associated with favorable prognosis in a variety of cancer settings. However, the role of immunity in breast cancer remains controversial. The purpose of this study was to determine the significance of tumor infiltrating leukocytes (TIL) with respect to pathological features and patient survival in estrogen receptor alpha (ER) negative breast cancer.. Patients and Methods: Tissue microarrays and immunohistochemistry were used to assess and categorize TIL in a cohort of 255 ER-negative invasive ductal breast carcinomas. Cases were registered by the Manitoba Breast Tumor Bank during the years 1988 to 2000 and had a minimum follow-up of 36 months. Stromal and intraepithelial TIL expressing the markers CD3, CD8, CD4, TIA1, CD25, FOXP3, CD20, CD68, and ...
  http://clincancerres.aacrjournals.org/content/16/7_Supplement/B13
*  Invasive Ductal Carcinoma [image] | EurekAlert! Science News
Invasive ductal carcinoma (IDC) cells (blue/purple) fill the entire image, as they have formed a large lump or mass in the patient's breast.
  https://www.eurekalert.org/multimedia/pub/69203.php?from=261217
*  Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers - Full Text View - ClinicalTrials...
To compare ductal carcinoma in situ (DCIS)-optimized MRI with standard clinical MRI, in terms of conspicuity of DCIS lesion, agreement of disease extent with biopsy, and overall image quality (i.e., artifact level, uniformity of fat suppression, contrast to noise ratio and signal to noise ratio), in women with DCIS of the breast ...
  https://clinicaltrials.gov/ct2/show/NCT00804128?term=dcis&rank=9
*  Plus it
Purpose: The present study analyzed the polymorphisms of DNA repair genes and their impact on survival of patients with early breast cancer.Patients and methods: A total of 240 patients with surgically resected early invasive ductal breast cancer were enrolled in the present study, where patients who underwent neoadjuvant treatment were excluded. The genomic DNA was extracted from paraffin-embedded tumor-free tissue or blood, and thirteen single nucleotide polymorphisms of 12 DNA repair genes were determined using the Sequenom Mass array system.Results: Among the target SNPs, VARS2 rs2074511 and POLE rs5744857 were found to correlate with relapse-free survival (RFS) after curative surgery in the log-rank test. There was no difference in the clinical and tumor characteristics according to the genotypes of these two coding variants except for the higher incidence of positive ER in patients with the GG genotype of POLE ...
  http://cancerres.aacrjournals.org/content/69/24_Supplement/6055
*  Breast Cancer, Infiltrating Ductal Carcinoma, Healed with an Herbal Protocol (Hollie Quinn) ⁄ Cancer Compass~An Alternate Route
Hollie Quinn suffered from the typical health complaints of an adult female; these included heartburn and acid reflux, along with painful cysts, vertigo and migraines.. Hollie says that she ate the typically American diet which was low in vegetables, high in sugar, and drank soda daily. She never questioned the health directives given to her by her doctors, and was never told that there might be a connection between her health issues and the diet that she was eating.. In 2002, when Hollie was just 27 years old and in her 38th week of pregnancy, she was diagnosed with an infiltrating ductal carcinoma. This is the most common type of breast cancer which affects some 80% of patients, and as its name suggests, the cancer had broken through the milk duct and was invading the surrounding tissues of the breast. Over time, invasive ductal carcinomas can spread to ...
  https://cancercompassalternateroute.com/testimonials/breast-cancer-infiltrating-ductal-carcinoma-healed-with-a-herbal-oncology-protocol-hollie-quinn/
*  Plus it
The expression of several members of the FOX gene family is known to be altered in a variety of cancers. We show that in breast cancer, FOXF1 gene is a target of epigenetic inactivation and that its gene product exhibits tumor-suppressive properties. Loss or downregulation of FOXF1 expression is associated with FOXF1 promoter hypermethylation in breast cancer cell lines and in invasive ductal carcinomas. Methylation of FOXF1 in invasive ductal carcinoma (37.6% of 117 cases) correlated with high tumor grade. Pharmacologic unmasking of epigenetic silencing in breast cancer cells restored FOXF1 expression. Re-expression of FOXF1 in breast cancer cells with epigenetically silenced FOXF1 genes led to G1 arrest concurrent with or without apoptosis to suppress both in vitro cell growth and in vivo ...
  http://cancerres.aacrjournals.org/content/early/2010/06/23/0008-5472.CAN-10-1576
*  What is ductal carcinoma? | Reference.com
Ductal carcinoma is cancer that starts in the milk ducts of the breast. The disease can be either ductal carcinoma in situ, or DCIS, which is the earliest stage of breast cancer and highly treatable;...
  https://www.reference.com/health/ductal-carcinoma-7f336c4906477510
*  Diagnostic and prognostic relevance of Cullin1 expression in invasive ductal carcinoma of the breast | Journal of Clinical...
Results Tumour expression of Cul1 was correlated with prognostic factors such as high histological grade and p53 expression, and was also linked to negative ER and positive HER2 as therapeutic markers (all p,0.05). There was a significant association between poor overall survival and high Cul1 expression in both univariate and multivariate analyses (all p,0.05). ...
  http://jcp.bmj.com/content/65/10/896
*  The distribution of ductal carcinoma in situ DCIS grade in 4232 women and its impact on overdiagnosis in breast cancer...
The distribution of ductal carcinoma in situ DCIS grade in 4232 women and its impact on overdiagnosis in breast cancer screening. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
  http://libros.duhnnae.com/2017/jul4/149906875740-The-distribution-of-ductal-carcinoma-in-situ-DCIS-grade-in-4232-women-and-its-impact-on-overdiagnosis-in-breast-cancer-screening.php
*  penny364 - Survivor: Breast Cancer | Ductal carcinoma in situ (DCIS)- Finished active treatment less than 5 years ago
penny364 - Survivor: Breast Cancer > Ductal carcinoma in situ (DCIS) Patient Info: Finished active treatment less than 5 years ago, Diagnosed: about 5 years ago, Female, Age: 71, Stage 0, HER2 Positive: No, ER Positive: Yes, PR Positive: Yes
  https://www.whatnext.com/users/penny364
*  Ductal carcinoma in situ (DCIS) - Patient kas12's Journey with Breast Cancer - WhatNext.com
Patient: Breast Cancer | Ductal carcinoma in situ (DCIS) Patient Info: Newly diagnosed (has not begun treatment), Diagnosed: over 4 years ago, Female, Age: 44, Stage 0, HER2 Positive: Don't Know, ER Positive: Don't Know, PR Positive: Don't Know
  https://www.whatnext.com/diagnoses/122981-ductal-carcinoma-in-situ-dcis/journey
*  Ductal carcinoma in situ (DCIS) - Patient ladybug's Journey with Breast Cancer - WhatNext.com
Patient: Breast Cancer | Ductal carcinoma in situ (DCIS) Patient Info: Finished active treatment less than 5 years ago, Diagnosed: about 6 years ago, Female, Age: 71, Stage 0, HER2 Positive: Don't Know, ER Positive: Yes, PR Positive: Yes
  https://www.whatnext.com/diagnoses/49941-ductal-carcinoma-in-situ-dcis/journey
*  Invasive (Infiltrating) Ductal Carcinoma - Survivor threewillows's Journey with Breast Cancer - WhatNext.com
Survivor: Breast Cancer | Invasive (Infiltrating) Ductal Carcinoma Patient Info: Finished active treatment less than 5 years ago, Diagnosed: about 8 years ago, Female, Age: 61, Stage I, HER2 Positive: No, ER Positive: Yes, PR Positive: Yes
  https://www.whatnext.com/diagnoses/69291-invasive-infiltrating-ductal-carcinoma/journey
*  Invasive (Infiltrating) Ductal Carcinoma - Survivor JNW's Journey with Breast Cancer - WhatNext.com
Survivor: Breast Cancer > Invasive (Infiltrating) Ductal Carcinoma Patient Info: Finished active treatment less than 5 years ago, Diagnosed: almost 4 years ago, Female, Age: 47, Stage III, HER2 Positive: No, ER Positive: Yes, PR Positive: Yes
  https://www.whatnext.com/diagnoses/299965-invasive-infiltrating-ductal-carcinoma/journey
*  mickmca15 - Patient: Breast Cancer | Invasive (Infiltrating) Ductal Carcinoma - Newly diagnosed (has not begun treatment)
mickmca15 - Patient: Breast Cancer | Invasive (Infiltrating) Ductal Carcinoma Patient Info: Newly diagnosed (has not begun treatment), Diagnosed: 10 months ago, Female, Age: 63, Stage III, HER2 Positive: Yes, ER Positive: No, PR Positive: No
  https://www.whatnext.com/users/mickmca15
*  Invasive (Infiltrating) Ductal Carcinoma - Survivor Sharnold83's Journey with Breast Cancer - WhatNext.com
Survivor: Breast Cancer | Invasive (Infiltrating) Ductal Carcinoma Patient Info: Finished active treatment less than 5 years ago, Diagnosed: almost 7 years ago, Female, Age: 34
  https://www.whatnext.com/diagnoses/25361-invasive-infiltrating-ductal-carcinoma/journey
*  Invasive (Infiltrating) Ductal Carcinoma - Patient bcsx2011's Journey with Breast Cancer - WhatNext.com
Patient: Breast Cancer | Invasive (Infiltrating) Ductal Carcinoma Patient Info: Finished active treatment less than 5 years ago, Diagnosed: almost 7 years ago, Female, Age: 52, Stage IIB, HER2 Positive: No, ER Positive: Yes, PR Positive: Yes
  https://www.whatnext.com/diagnoses/21431-invasive-infiltrating-ductal-carcinoma/journey